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ABSTRACT (100-200 WORDS): The characterization of the binding properties of the Zinc 
ion, a metal cofactor, for the IspF enzyme can reveal details of critical interactions that allows to 
better understand IspF function. The use of Isothermal Titration Calorimetry (ITC) was used to 
determine the binding affinity of the Zn2+ cofactor to the IspF enzyme. A sample of IspF was 
titrated with a Zinc solution, using a Zinc to Buffer titration as a control. This was done to isolate 
ligand and protein interactions from the interference of buffer solution. The titration of the Zn2+ 
cofactor can reveal insight into the binding thermodynamics with Burkholderia pseudomallei 
IspF. Further studies will be carried out against another IspF sample from Escherichia coli, as 






















The characterization of the binding properties of the Zinc ion, a metal cofactor, for the IspF 
enzyme can reveal details of critical interactions that allows to better understand IspF function. 
The use of Isothermal Titration Calorimetry (ITC) was used to determine the binding affinity of 
the Zn2+ cofactor to the IspF enzyme. A sample of IspF was titrated with a Zinc solution, using a 
Zinc to Buffer titration as a control. This was done to isolate ligand and protein interactions from 
the interference of buffer solution. The titration of the Zn2+ cofactor can reveal insight into the 
binding thermodynamics with Burkholderia pseudomallei IspF. Further studies will be carried 
out against another IspF sample from Escherichia coli, as well as other 2+ metal ions like 
Magnesium (Mg2+) and Calcium (Ca2+). 
Introduction 
Isoprenoids are a group of natural compounds that are vital to cellular functions and membrane 
stability1. Two pathways are responsible for the biosynthesis of these compounds are the 
Mevalonate Pathway (MVA) and the Methylerythritol Phosphate (MEP) Pathway (Scheme 1)2. 
The MVA Pathway is found in eukaryotes, archaea, and some bacteria3. The MEP Pathway is 
found in bacteria, plants, and some protozoa4. 
 
  
Scheme 1: Flow chart representation of the Mevalonate (MVA) Pathway and the Non-mevalonate (MEP) Pathway  
 Scheme 2: Reaction mechanism of IspF with metal cofactors Zn2+ and Mg2+.3 
 
The MEP Pathway has seven enzymes in the biosynthesis of isoprenoids. IspF is the 5th step in 
this process, converting CDP-ME2P to MECDP (Scheme 2). The focus of this project is 
determining the binding affinity of the Zn2+ cofactor that is necessary for its catalytic function. 
 
 
Figure 1: Crystal structure of Burkholderia pseudomallei IspF (PDB: 3P10). Yellow spheres indicate catalytic Zinc ions. 
The IspF enzyme binds to the Zinc ion from the organism Burkholderia pseudomallei. 
Burkholderia pseudomallei is the bacterium species responsible for melioidosis, also known as 
Whitmore’s disease, and is predominately found within contaminated water and soil of tropical 
climates5. These locations include Northern Australia and Southeast Asia. The bacterium is 
contacted directly through waterways, ingestion, inhalation, or through cattle or swine. Infection 
begins in the lungs and can spread to vital organs via bloodstream. Symptoms include fever, 
headache, and aching of body. Serious infection of the lungs result in large amount of pus and if 
left untreated can be fatal. In many cases, symptoms do not present or is latent until those 
infected are at lowest resistance. 
 
Each of the three active sites of the IspF trimer contain a catalytic Zinc ion, which is critical for 
its catalytic activity. Characterization of the binding properties of the zinc ion for the IspF 
enzyme will reveal details of a critical interactions that will allow us to better understand IspF 
function as well as help in the design of new potential IspF inhibitors that target the Zinc ion.  
 
Targeting Zinc in BpIspF can assist in disrupting the MEP Pathway. Non-melvonate pathway 
(MEP Pathway) is an essential pathway for plant and microbial organism life, not in mammals, 
specifically humans. By targeting enzymes within the MEP pathway can inhibit microbial 
growth, which prevents melioidosis from infecting mammals. Resistance is not a concern 
because Burkholderia pseudomallei is completely dependent upon the MEP Pathway to produce 
isoprenoids.  Mammals will not be negatively impacted upon the removal of the catalytic Zinc 
ion in IspF because they do not depend on the MEP Pathway for existence. Mammals function 
with their own separate and essential pathway, which is the MVA Pathway (Mevalonate 
Pathway) to produce isoprenoids. Understanding that the disruption of the MEP Pathway will 
destroy the bacteria without disrupting the isoprenoid biosynthesis of humans will benefit future 
drug design through elimination of side effects. 
 
 
Figure 2: Small molecules which bind BpIspF fall into three distinct categories: a cytidine pocket binders, including cytosine 
(yellow), cytidine (cyan), 50-iodo-cytidine (green), CMP (navy), CDP (magenta) and CTP (white); b zinc-site binders FOL535 
(magenta), FOL717 (navy), FOL8395 (cyan) and FOL955 (white); and c external site binders FOL694 (magenta) and FOL795 
(cyan). A single protein crystal structure (PDB ID: 3P10) is, depicted for clarity. Key interactions illustrated in a between 
cytidine, D48 of one monomer, and A102, P105 and A108 of the opposite monomer (black dashes). Cytidine and FOL955 (white) 
are illustrated in the active site for c. Figure generated using PyMol. 
Methods 
Purified BpIspF provided by SSGCID 
 Organism: Burkholderia pseudomallei 1710b 
 Center Reference ID: BupsA.00122.a 
 Initial Concentration = 3.77 mM 
 Final Concentration = 38.23 uM 
Buffer dialysis w/ EDTA multiples times: 10mM EDTA, 200mM NaCl, 25mM Tris, 1% 
Glycerol, pH 8.0 
 Zinc is removed from BpIspF using Ethylenediaminetetraacetic acid (EDTA). EDTA6 is 
a chelating agent, which is a chemical that binds strongly to metal ions. The addition of 
EDTA to the buffer solution will aid in the removal of the catalytic Zinc ion from 
BpIspF. Once made and set, the enzyme solution is placed inside a semi-permeable 
membrane in the buffer solution. The solution is set to diffuse overnight to make sure 
that the Zinc ion diffuses out of BpIspF. 
Buffer dialysis w/out EDTA multiple times: 1mM TCEP, 200mM NaCl, 25mM Tris, 1% 
Glycerol, pH 8.0 
Because the presence of EDTA in the enzyme will interfere with the data from ITC, it is 
mandatory to purify the enzyme without the Zinc ion7. A buffer dialysis solution is made 
without EDTA. Once made and set, the enzyme solution is placed inside a semi-
permeable membrane in the buffer solution. The solution is set to diffuse EDTA and 
remaining Zinc ions attached to EDTA from BpIspF 
ZnCl2 diluted with 2
nd dialysis buffer to guarantee buffer matching at a final concentration of 
1.005 mM 
Approximately 1.005M solution was made with ZnCl2 was made and diluted further with     
dialysis buffer (without EDTA). 
Binding Thermodynamics determined through Isothermal Titration Calorimetry 
 MicroCalTM VP-ITC (Isothermal Titration Calorimetry) is used to analyze the binding 
thermodynamics of BpIspF by adding the zinc ion back into the protein to analyze 
binding strength. It allows for the determination of binding thermodynamics. A second 
ITC run is performed between the ligand and buffer to isolate the binding between only 
the ligand and protein.  
 
Figure 3: Simple representation of a buffer dialysis 
                                 
Figure 4: Graphical representation of collected ITC data          Figure 5: Representation of MicroCalTM VP-ITC instrumentation8 
Ideally, initial large peaks reveal immediate binding of the Zinc (Zn 2+) metal cofactors to the 
three catalytic binding sites of BpIspF. As binding occurs, there are less sites available for 
binding to the protein due to saturation of Zinc ions. This, in turn reduces the amount of binding 
as the titrations of ZnCl2 progress and creates a sigmoidal binding curve.  
Inside the ITC is a reference cell filled with distilled water. The sample cell is filled with the 
protein, while the syringe contains the ligand (ZnCl2). The water serves as a comparison cell for 
heat that occurs as the machine runs. It allows source of the heat generated in the instrument to 
be known.  
 
Results & Discussion 
 
Figure 5: Data retrieved after run of experiment performed 
Large peaks are seen during each injection throughout the course of the ITC experimentation. 
This indicates very strong binding of ligand (Zn2+) to the protein target (BpIspF). No decrease in 
peak intensity indicating incomplete saturation of binding sites available in the protein sample. 
The binding curve is represented with a positive linear slope, showing that binding is constantly 
increasing. Due to this, the data does not fit the appropriate model for ligand binding. Further 
studies are necessary for actual quantification of the binding affinity of BpIspF to Zn2+. 
 
Figure 6: Binding curve of experiment performed 
Conclusion 
     Large peaks reveal immediate binding of the Zinc (Zn 2+) metal cofactors to the three catalytic 
binding sites of BpIspF.  In addition, the remnants of EDTA allows for another binding sites for 
Zinc (due to insufficient multiple buffer dialysis's following Zn2+ removal to fully remove 
EDTA). Once the binding sites are saturated with Zinc, the peaks should decrease in height as 
these sites are taken up by Zinc metal cofactors as there are less open binding sites for the ligand. 
Because the concentration of Zinc was not enough to saturate the binding sites of BpIspF, with 
each titration was immediate binding to the ligand. This is the reason why large peaks continue 
to appear with titration and do not decrease in height to result in a sigmoidal bind curve. 
     Further Studies will be conducted using a modified buffer solution and with a greater 
concentration ratio of the Zinc (Zn2+) metal cofactor to Burkholderia pseudomallei IspF in an 
attempt to further quantify the binding affinity of the Zinc cofactor to BpIspF. Multiple buffer 
dialysis’s will be done after the stripping of the metal cofactor from BpIspF to fully remove 
EDTA. Studies will also be carried out with other 2+ metal ions, such as Magnesium (Mg2+) 
which is another ion necessary for catalytic function, and Calcium (Ca2+). The same 
experimentation will also be carried out against IspF from Escherichia coli. 
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